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Ssmoking habits, hypertension and hyperlipidaemia and in use of UH/LMWH and
drug-eluting stents during the procedure. RA patients were more likely to be pre-
treated with aspirin, clopidogrel and to receive bivalirudin. FA patients were more
likely to had previous myocardial infarction, previous PCI, previous coronary CABG
and to receive GP IIb/IIIa. There were 600 patients (41.1%) with STEMI and 858
(58.9%) with UA/NSTEMI. More patients with STEMI underwent PCI through FA.
There was no difference in 30-days mortality between the RA and FA group (5.5% vs.
6.3%; HR 1.2; 95% CI 0.73–2.0; p ¼ 0.46).
Conclusions: In this study, PCI through radial artery access was not associated with
reduced 30-days mortality in octogenarians with acute coronary syndromes. Properly
designed randomised clinical trial is needed to test whether radial artery access may
decrease mortality in octogenarians.
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Background: Treatment of complex lesions in coronary arteries with aneurysms,
ectasia, or tapering remains challenging due to a high risk of vessel wall-stent diameter
mismatch. The self-apposing STENTYS stent (STENTYS SA, Paris, France) is
designed to adjust to variable vessel diameters, which may optimize the vessel wall-
stent match and reduce the risk of stent malapposition. STENTYS is extensively
evaluated in ST-segment elevation myocardial infarction (STEMI) patients, but there
is a paucity of data of other treatment indications. We evaluated the feasibility and
safety of the STENTYS stent in complex lesions with a high risk of diameter
mismatch.
Methods: We included consecutive patients treated with STENTYS between April
2010 and June 2013 because of angiographic characteristics with a high risk of
diameter mismatch, including aneurysms, ectasia, tapering, bifurcation lesions, and
saphenous vein graft (SVG). STEMI patients were excluded. Angiographic success
was deﬁned as ﬁnal residual stenosis <5 % in the target vessel with TIMI 3 ﬂow.
Procedural success was deﬁned as angiographic success without in-hospital cardiac
death, myocardial infarction (MI) or target vessel revascularization (TVR).
Results: A total of 87 patients were included, mean age was 6512 years. Indications
for the STENTYS stent were; aneurysm: 25(29%), ectasia: 21(24%), tapering:
27(31%), bifurcation: 22(25%), and SVG: 9(10%). In some target vessels 2 indi-
cations applied. Angiographic and procedural success was achieved in 92% and 91%
respectively. In 6(8%) patients there was 5% residual stenosis on visual estimate,
which might improve over time due to the stents self-apposing properties, 1 patient
suffered from an in-hospital MI. No peri-procedural complications occurred.
Conclusions: Early angiographic and procedural success of treatment with the
STENTYS stent, in patients other than STEMI, are favourable. This single-center
experience provides novel insights of angiographic and procedural outcome in
complex lesions with a high risk of diameter mismatch. Long-term clinical follow-up,
which will be available at TCT, is needed to evaluate whether the self-apposing stent
technique translates into favourable clinical outcomes.
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Background: Soｍe trials have suggested that transradial intervention (TRI) reduces
vascular complications and bleeding compared with transfemoral intervention (TFI).
However, the long term outcomes are still not clear in patients with ST-segment
elevation myocardial infarction (STEMI). In this study, we aimed to assess the
feasibility and the long term outcomes of TRI in patients with who underwent primary
percutaneous coronary intervention (PCI).
Methods: This study was multicenter,retrospective observational study. Between
January 2006 and December 2010, a total of 550 STEMI patients underwent primary
PCI. Out of these patients, TRI was performed in 208 patients and TFI was performed
in 342 patients. Mean follow-up period was 3325 months. Outcome measures were
in-hospital complications (all-cause death,recurrent myocardial infarction,stroke,major
bleeding) and major adverse cardiovascular events (MACE: all-cause death,target
vessel revascularization (TVR), recurrent myocardial infarction, admission of heart
failure) at 3 years.
Results: There was no statistical difference in patients characteristics between two
groups. During the initial hospitalization, the complications rate was 2.9% in TRIB16 JACC Vol 62/18/Suppl B j October 27–Novembegroup and 9.4% in TFI group (P¼0.004). Kaplan-Meier survival curves showed that
the freedom from MACE was 76.9% in TRI vs 68.4% in TFI at three years(P¼0.03).Conclusions: Both the in-hospital complications and the difference in freedom from
MACE at 3 years were statistically lower in TRI group compared with TFI group.Miscellaneous Coronary Intervention
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Background: Percutaneous coronary intervention (PCI) in the setting of acute
myocardial infarction (MI) is known to predict stent thrombosis. However, the
association between the spectrum of clinical presentation and stent thrombosis after
PCI has not been well deﬁned. This study aims to compare the stent thrombosis rates
across the acuity of clinical presentation for PCI.
Methods: The study included a cohort of 12198 consecutive patients who underwent
PCI. Patients were categorized according to their clinical presentation: stable angina
pectoris (SAP, n¼3700), unstable angina pectoris (UAP, n¼2845), non ST-segment
elevation MI (NSTEMI, n¼4083), and ST-segment elevation MI (STEMI, n¼1570).
The ARC-deﬁned stent thrombosis rates were compared among the groups.
Results: Antiplatelet loading was similar across groups (85% overall). The use of
drug-eluting stents (DES) in STEMI pts. was 51.3%, 73% in NSTEMI, 77.4% in
UAP, and 77.7% in SAP. One-year deﬁnite stent thrombosis rates were highest in
STEMI compared to other groups. (Figure) Similarly, rates of probable stent throm-
bosis increased with the acuity of the clinical presentation: lowest in UAP and highest
in STEMI. The majority of deﬁnite (71.4%) and probable (66.6%) stent thrombosis
occurred early (within 30 days). The rates of death and myocardial infarction corre-
sponded with the acuity of clinical presentation.
Conclusions: In patients undergoing PCI, the acuity of clinical presentation corre-
sponds to an increase in the incidence of stent thrombosis. A pro-inﬂammatory milieu
promoting thrombosis and delaying endothelial healing may contribute to this.r 1, 2013 j TCT Abstracts/ORAL/Miscellaneous Coronary Intervention
